The International Youth Development Foundation (IYDF), in partnership with Rao Study Circle, organized a compassionate outreach event for underprivileged children in the Dhurwa, Sector-01 community of Ranchi, Jharkhand. These children's families primarily rely on unstable sources of income, such as agriculture, construction, daily wage labor, and domestic work, which puts significant strain on their access to education and healthcare. To support these children, Hare Krishna Rao, the head of Rao Study Circle, took the initiative to bring together resources and support from various sectors of society.
The event was supported by a dedicated team of volunteers, including Prag Bhusan, Ranjani Kumari, Mukul Anand, Shivam Kumar, Shorya Pratik, Neelam Devi, and Naveen Sinha. They not only provided essential supplies for the children’s daily needs and education but also spent an afternoon filled with joy and warmth with the children.
Despite the unfavorable weather in Ranchi on the event day, the children's excitement and enthusiasm were undiminished. As soon as the volunteers arrived in the Dhurwa community, they were greeted with smiles and open arms. The aid distributed included rice, flour, lentils, sugar, vegetable oil, soy chunks, and stationery. While these items may seem simple, they are crucial for these children and their families.
Hare Krishna Rao expressed his hopes for the event, stating, “Through this activity, we aim not only to alleviate the immediate challenges these children face but also to make them feel the love and support of society, helping them develop a positive and hopeful outlook.”
During the distribution of aid, the volunteers engaged with the children through singing and music, creating a lively and joyful atmosphere. Prag Bhusan and Ranjani Kumari led the children in singing, their faces lighting up with happiness. Their enthusiastic participation brought immense joy to the volunteers. Prag Bhusan reflected, “Seeing the children's bright smiles as we sang is indescribably fulfilling. It reminds us that even in adversity, they hold onto hope for life.”
Notably, Smt. Neelam Chaudhary, State Minister of Women's Wing (Mahila Morcha) of Bharatiya Janata Party (BJP), was also invited to attend the event. Her presence added to the excitement of both the children and the volunteers. She assisted in distributing supplies and engaged in warm conversations with the children to learn about their lives and studies. She remarked, “Every child deserves a future filled with hope. Today's event has shown me their resilience and optimism. Our society needs to pay more attention to these vulnerable groups and help them overcome their challenges.”
Towards the end of the event, Mukul Anand and Neelam Devi had brief dialogues with the children, encouraging them to persevere in their studies and not give up on their dreams despite life's hardships. Shorya Pratik concluded, “What we've done today goes beyond material assistance; it's about showing these children that the future is still full of hope.”
This outreach event not only provided material assistance to the underprivileged children of the Dhurwa community but also offered them emotional support and encouragement. The volunteers from IYDF and Rao Study Circle conveyed warmth and compassion through their actions, helping these children maintain their smiles and steadfastly pursue their dreams in the face of adversity.
IYDF and Rao Study Circle Provide Support to Underprivileged Children in Dhurwa Community, Volunteers Unite to Build Hope<br>

The day in focus. Delivered to your inbox.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.More to Read
Brutus Mining Announces Closing of $3.0 Million Private Placement Financings
VANCOUVER, British Columbia, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Brutus Mining Inc. (“ Brutus ” or the “ Company ”) ( CSE: BRU ) ( FSE: ZI3 ) is pleased to announce that it has closed its non-brokered private placements previously announced on September 21, 2026 (together, the “ Offerings ”) for aggregate gross proceeds of $2,998,725.05. The Company issued 5,710,643 units (each, a “ Unit ”) at a price of $0.35 per Unit for gross proceeds of $1,998,725.05. Each Unit is comprised of one (1) common s
Nordique Critical Metals Announces TSXV Final Approval for its Acquisition of Option to Earn Up to 80% Interest in the Kwyjibo Rare Earth Project in Québec; Files Amended 2026 Kwyjibo PEA Report
MONTREAL, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Nordique Critical Metals Inc. (formerly, Consolidated Lithium Metals Inc.) (TSXV: NQC | FRA: J6K | OTCQB: JORFF) (“NQC” or the “Company”) is pleased to announce that it has received final approval from the TSX Venture Exchange (“TSXV”) for its previously announced acquisition of an option to earn, subject to the satisfaction of certain conditions, an undivided interest of up to 80% in the Kwyjibo Rare Earth Project (“Kwyjibo, or the “Project”), located
Innohealth 2026 Brings Ohio's Life Sciences Leaders Together on the Talent, Research and Capital That Will Drive the Next Decade of Growth
JobsOhio and Ohio Life Sciences convened leaders from Resilience, Hikma, The Ohio State University, Nationwide Children's Hospital and Ohio's fastest-growing health startups Columbus, Ohio, Oct. 13, 2026 (GLOBE NEWSWIRE) -- The next decade of U.S. life sciences growth will be won by the states that can train a workforce at the speed of construction, translate discoveries into life-saving products and companies, and keep high-growth businesses operating close to home. More than 250 executives, re
TRexBio Announces Closing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. (“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines, today announced the closing of its initial public offering of 8,333,334 shares of its common stock at the initial public offering price of $14.00 per share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commission
Strive Announces Proposed Initial Public Offering of SATS Stock
DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST) (“Strive” or the “Company”) today announced that, subject to market and other conditions, it intends to conduct an initial public offering (the “offering”) registered under the Securities Act of 1933, as amended (the “Securities Act”), of 5,000,000 shares of Strive’s 15.00% Series A Perpetual SATS Preferred Stock, par value $0.001 per share (the “SATS Stock”). Strive intends to use the net proceeds from the offering for genera
Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Press release – No. 20 / 2026 Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multispecific drug candidates with tailored biological functions Generate will receive USD 30 million up-front, up to USD 35 million in early preclinical milestones, and a total
Foresight Reports 2026 Third Quarter and Nine-Month Results
WINNEBAGO, Ill., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Foresight Financial Group, Inc. (OTCQX: FGFH) reported net income of $4.27 million for the quarter ended September 30, 2026, a 167% increase compared to $1.60 million reported for the third quarter of 2025 and a 2% decrease compared to $4.38 million reported for the second quarter of 2026. Diluted earnings per share were $1.18 for the quarter compared to $0.44 for the third quarter of 2025 and $1.20 for the second quarter of 2026. The third quar
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multispecific drug candidates with tailored biological functions Generate will receive $30M upfront, up to $35M in early preclinical milestones, and a total of up to nearly $1.2B in milestones, plus tiered royalties for two initial programs, with an option to add a third The agreement will broaden Zealand Pharma’s modality capabilities beyond peptides while exten
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!